HOXD10 expression in human breast cancer

Tumor Biology

Volumn 35, Issue 11, 2014, Pages 10855-10860

  Vardhini, N V ^a   Rao, P Jagan Mohan ^a   Murthy, P Balakrishna ^a   Sudhakar, G ^b  

^a International Institute of Biotechnology and Toxicology IIBAT   (India)

^b ANDHRA UNIVERSITY   (India)

Author keywords

Biomarker; Gene expression; HOXD10 gene; Human breast cancer; Quantitative real time PCR

Indexed keywords

HOMEODOMAIN PROTEIN; HOXD10 PROTEIN, HUMAN; MESSENGER RNA; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; BREAST; BREAST TUMOR; CANCER GRADING; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GENETICS; HUMAN; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HOMEODOMAIN PROTEINS; HUMANS; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84928587449     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2324-z     Document Type: Article

References (31)

1. Globocan 2012;http://globocan.iarc.fr
2. Murthy NS, Chaudhry K, Nadayil D, Agarwal UK, Saxena S. The changing trends of breast cancer, the Indian scenario. Indian Journal Of Cancer National Cancer Registry Programme ICMR, Division of Non-Communicable Diseases, Indian Council of Medical Research. Indian J Cancer. 2009;46:73–7.
3. Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA. 2003;289:1421–4.
4. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530–6.
5. Sotiriou C, Pusztai L. Gene expression signatures in breast cancer. N Engl J Med. 2009;360:790–800.
6. Krumlauf R. Hox genes in vertebrate development. Cell. 1994;70:191–201.
7. Zakany J, Kmita M, Duboule D. A dual role for Hox genes in limb anterior-posterior asymmetry. Science. 2004;304:1669–72.
8. Redline RW, Williams AJ, Patterson P, Collins T. Human HOX4E, A gene strongly expressed in the adult male and female urogenital tracts. Genomics. 1992;13:425–30.
9. Abate-Shen C. Deregulated homeobox gene expression in cancer, cause or consequence? Nat Rev Cancer. 2002;2:777–85.
10. Samuel S, Naora H. Homeobox gene expression in cancer, insights from developmental regulation and deregulation. Eur J Cancer. 2005;41:2428–37.
11. Robson EJ, He SJ, Eccles MR. A panorama of PAX genes in cancer and development. Nat Rev Cancer. 2006;6:52–62.
12. Osborne J, Hu C, Hawley C, et al. Expression of HOXD10 gene in normal endometrium and endometrial adenocarcinoma. J Soc Gynecol Invest. 1998;5:277–80.
13. Makiyama K, Hamada J, Takada M. Aberrant expression of HOX genes in human invasive breast carcinoma. Oncol Rep. 2005;13:673–9.
14. Redline RW, Hudock P, MacFee M, Patterson P. Expression of AbdB-type homeobox genes in human tumors. Lab Invest. 1994;71:663–70.
15. Miller GJ, Miller HL. Adrie van Bokhoven Lambert JR, Priya, N, Werahera OS, Scott Lucia M, Steven K N et al. Aberrant HOXC expression accomplishes the malignant phenotype in human prostate. Cancer Res. 2003;63:5879–88.
16. Cantile M, Pettinato G, Procino A, Feliciello I, Cindolo L, Cillo C. In vivo expression of the whole HOX gene network in human breast cancer. Eur J Cancer. 2003;39:257–64.
17. Cantile M, Schiavo G, Terracciano L, Cillo C. The HOX gene network as a potential target for cancer therapy. Current Cancer Therapy Reviews. 2007;3:17–24.
18. ­ΔΔCT method. Methods. 2001;25:402–8.
19. Sobin LH, and Witterkind C(eds.). TNM classification of malignant tumours. 6th edition. Wiley-Liss, New York: 2002; 131–141.
20. Olson J. Bathsheba’s breast: women, cancer, and history. Baltimore: John Hopkins Press; 2002.
21. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucl Acids Res. 2002;30:e36.
22. Derveaux S, Vandesompele J, Hellemans. How to do successful gene expression analysis using real-time PCR. J Appl Meteorol. 2010;50:227–30.
23. Goetz MP et al. A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen. Clin Cancer Res. 2006;12:2080–7.
24. Jansen MP et al. HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study. J Clin Oncol. 2007;25:662–8.
25. Chou WC et al. Acute myeloid leukemia bearing t (7; 11) (p15; p15) is a cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients. Leukemia. 2009;23:1303–10.
26. Hedlund E, Karsten SL, Kudo L, Geschwind DH, Carpenter EM. Identification of a Hoxd10-regulated transcriptional network and combinatorial interactions with Hoxa10 during spinal cord development. J Neurosci Res. 2004;75:307–19.
27. Carrio M, Arderiu G, Myers C, Boudreau NJ. Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model. Cancer Res. 2005;65:7177–85.
28. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007;449:682–8.
29. Sun L et al. MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res. 2011;1389:9–18.
30. Wang L et al. Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis. Mol Med. 2012;18:389–400.
31. Hu X, Chen D, Cui Y, Li Z, Huang J. Targeting microRNA-23a to inhibit glioma cell invasion via HOXD10. Scientific Reports. 2013;3:3423.